Background <p>Cervical cancer is a significant public health problem globally, with limited access to screening and diagnostic resources in developing countries contributing to its high burden. Artificial Intelligence (AI) has emerged as a promising tool to enhance the diagnostic performance of colposcopy, a procedure used to visually examine the cervix for abnormal cell growth. The findings of this study will contribute to the growing body of evidence on the role of Artificial Intelligence (AI) in cervical cancer diagnosis.</p> Materials and Methods <p>This Meta-analysis aims to synthesize data and provide a comprehensive evaluation of the diagnostic performance of AI-assisted colposcopy systems (sensitivity, specificity, and accuracy) for Cervical malignancy and premalignant lesions.</p> <p>A comprehensive literature search was conducted across multiple databases, and 12 studies were included in the Meta-analysis. Pooled estimates of sensitivity, specificity, and accuracy were calculated using a random-effects model, and heterogeneity statistics were computed to evaluate consistency across studies.</p> Results <p>The pooled estimates of diagnostic performance were sensitivity, 78.1% (95% CI 71.4–84.0%); specificity, 80.6% (95% CI 74.2–85.8%); and accuracy, 83.1% (95% CI 77.8–88.2%). Subgroup analysis and heterogeneity testing were performed to explore sources of variability.</p> Conclusion <p>The results suggest that AI-assisted colposcopy systems demonstrate promising diagnostic performance in Cervical malignancy and premalignant lesions diagnosis. However, substantial heterogeneity underscores the need for methodological standardization and reporting transparency in AI-based diagnostic research. Future research should focus on developing and validating AI models in diverse populations, evaluating clinical utility and cost-effectiveness, and investigating the impact of AI-assisted colposcopy on patient outcomes and healthcare systems.</p>